Notice of Application - 2010
[Federal Register: November 12, 2010 (Volume 75, Number 218)]
[Notices]
[Page 69464-69466]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr12no10-87]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 16, 2009, Cerilliant
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in schedules I and II:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
| N,N-Dimethylamphetamine (1480) |
I |
| Aminorex (1585) |
I |
| 4-Methylaminorex (cis isomer) (1590) |
I |
| Gamma-Hydroxybutyric acid (2010) |
I |
| Methaqualone (2565) |
I |
| Alpha-ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide (7315) |
I |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) |
I |
| Marihuana (7360) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Mescaline (7381) |
I |
| 3,4,5-Trimethoxyamphetamine (7390) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) |
I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,5-Dimethoxy-4-ethylamphetamine (7399) |
I |
| 3,4-Methylenedioxyamphetamine (7400) |
I |
| 5-Methoxy-3,4-methylenedioxyamphetamine (7401) |
I |
| N-Hydroxy-3,4-methylendioxyamphetamine (7402) |
I |
| 3,4-Methylendioxy-N-ethylamphetamine (7404) |
I |
| 3,4-Methylenedioxymethamphetamine (7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| Alpha-methyltryptamine (7432) |
I |
| Bufotenine (7433) |
I |
| Diethyltryptamine (7434) |
I |
| Dimethyltryptamine (7435) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| 5-Methoxy-N,N-diisopropyltyptamine (7439) |
I |
| N-Benzylpiperazine (7493) |
I |
| Acetyldihydrocodeine (9051) |
I |
| Benzylmorphine (9052) |
I |
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Heroin (9200) |
I |
| Hydromorphinol (9301) |
I |
| Methyldihydromorphine (9304) |
I |
| Morphine-N-oxide (9307) |
I |
| Normorphine (9313) |
I |
| Pholcodine (9314) |
I |
| Acetylmethadol (9601) |
I |
| Allylprodine (9602) |
I |
| Alphacetylmethadol except levo-alphacetylmethadol (9603) |
I |
| Alphameprodine (9604) |
I |
| Alphamethadol (9605) |
I |
| Betacetylmethadol (9607) |
I |
| Betameprodine (9608) |
I |
| Betamethadol (9609) |
I |
| Betaprodine (9611) |
I |
| Hydroxypethidine (9627) |
I |
| Noracymethadol (9633) |
I |
| Norlevorphanol (9634) |
I |
| Normethadone (9635) |
I |
| Trimeperidine (9646) |
I |
| Phenomorphan (9647) |
I |
| 1-Methyl-4-phenyl-4-propionoxypiperidine (9661) |
I |
| Tilidine (9750) |
I |
| Para-Fluorofentanyl (9812) |
I |
| 3-Methylfentanyl (9813) |
I |
| Alpha-Methylfentanyl (9814) |
I |
| Acetyl-alpha-methylfentanyl (9815) |
I |
| Beta-hydroxyfentanyl (9830) |
I |
| Beta-hydroxy-3-methylfentanyl (9831) |
I |
| Alpha-Methylthiofentanyl (9832) |
I |
| 3-Methylthiofentanyl (9833) |
I |
| Thiofentanyl (9835) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Lisdexamfetamine (1205) |
II |
| Phenmetrazine (1631) |
II |
| Methylphenidate (1724) |
II |
| Amobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| Glutethimide (2550) |
II |
| Nabilone (7379) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| 1-Piperidinocyclohexanecarbonitrile (8603) |
II |
| Alphaprodine (9010) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Diphenoxylate (9170) |
II |
| Benzoylecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Levomethorphan (9210) |
II |
| Levorphanol (9220) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Meperidine intermediate-A (9232) |
II |
| Meperidine intermediate-B (9233) |
II |
| Meperidine intermediate-C (9234) |
II |
| Methadone (9250) |
II |
| Methadone intermediate (9254) |
II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Racemethorphan (9732) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Tapentadol (9780) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture small quantities of the listed
controlled substances to make reference standards which will be
distributed to their customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 11, 2011.
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-28516 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
